Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUMMIT: AXS-05 for Smoking Cessation
NCT07766655Phase 3Recruiting
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of dextromethorphan + bupropion in nicotine dependence, sponsored by Axsome Therapeutics, Inc.. Started Aug 2026; status: recruiting.
02
Drugs
dextromethorphan + bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT07766655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766655.